Eurofins Scientific Aktie - ERF

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

52,24

Gebot

52,00

Fragen

52,76

Volumen

0,00

0,00 Tagesbereich 0,00

39,47 52-Wochen-Bereich 62,10

Marktkapitalisierung

10,081B

Handelsende

52,24

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

398.544

Ausgegebene Aktien

192.981.183

Dividendenrendite

0.96%

Kurs-Gewinn-Verhältnis

24,81

Gewinn pro Aktie (EPS)

2,11

Erlöse

6,97B

Nettogewinn

406,4M

Sektor

Testing Laboratories

Branche

Testing Laboratories

Website

www.eurofins.com

Hauptsitz

Grand Duche Du, Lux

Gegründet

Eurofins Scientific SE is listed in the Testing Laboratories sector of the Euronext with ticker ERF. The last closing price for Eurofins Scientific was 52,24 €. Over the last year, Eurofins Scientific shares have traded in a share price range of 39,47 € to 62,10 €.

Eurofins Scientific currently has 192.981.183 shares in issue. The market capitalisation of Eurofins Scientific is 10,08 € billion. Eurofins Scientific has a price to earnings ratio (PE ratio) of 24.81.

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in...

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and...

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de...

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs...

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé...

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and...

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	3.24	6.61224489796	49	52.92	48.91	524136	51.05222926	DE
4	0.8	1.55520995334	51.44	52.92	47.89	426700	49.76545237	DE
12	4.64	9.74789915966	47.6	52.92	45.56	398544	49.33683311	DE
26	-0.66	-1.24763705104	52.9	58.24	44.52	396171	49.47397102	DE
52	-3.2	-5.77200577201	55.44	62.1	39.47	394950	51.2083767	DE
156	-31.33	-37.4895297356	83.57	100.5	39.47	388367	60.57355953	DE
260	-376.36	-87.8114792347	428.6	754	39.47	329713	78.01874529	DE

ERF - Frequently Asked Questions (FAQ)

What is the current Eurofins Scientific share price?

The current share price of Eurofins Scientific is 52,24 €

How many Eurofins Scientific shares are in issue?

Eurofins Scientific has 192.981.183 shares in issue

What is the market cap of Eurofins Scientific?

The market capitalisation of Eurofins Scientific is EUR 10,08B

What is the 1 year trading range for Eurofins Scientific share price?

Eurofins Scientific has traded in the range of 39,47 € to 62,10 € during the past year

What is the PE ratio of Eurofins Scientific?

The price to earnings ratio of Eurofins Scientific is 24,81

What is the cash to sales ratio of Eurofins Scientific?

The cash to sales ratio of Eurofins Scientific is 1,45

What is the reporting currency for Eurofins Scientific?

Eurofins Scientific reports financial results in EUR

What is the latest annual turnover for Eurofins Scientific?

The latest annual turnover of Eurofins Scientific is EUR 6,97B

What is the latest annual profit for Eurofins Scientific?

The latest annual profit of Eurofins Scientific is EUR 406,4M

What is the registered address of Eurofins Scientific?

The registered address for Eurofins Scientific is 23 VAL FLEURI, GRAND DUCHE DU, L-1526

What is the Eurofins Scientific website address?

The website address for Eurofins Scientific is www.eurofins.com

Which industry sector does Eurofins Scientific operate in?

Eurofins Scientific operates in the TESTING LABORATORIES sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ABCAABC Arbitrage	5,29 € (0,00%)	0
ABAb Science	1,412 € (0,00%)	0
AALBAalberts NV	34,74 € (0,00%)	0
AAAAlan Allman Associates	4,68 € (0,00%)	0
74SW74Software SA	30,40 € (0,00%)	0
ABCAABC Arbitrage	5,29 € (0,00%)	0
ABAb Science	1,412 € (0,00%)	0
AALBAalberts NV	34,74 € (0,00%)	0
AAAAlan Allman Associates	4,68 € (0,00%)	0
74SW74Software SA	30,40 € (0,00%)	0
ABCAABC Arbitrage	5,29 € (0,00%)	0
ABAb Science	1,412 € (0,00%)	0
AALBAalberts NV	34,74 € (0,00%)	0
AAAAlan Allman Associates	4,68 € (0,00%)	0
74SW74Software SA	30,40 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Eurofins Scientific SE (ERF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Eurofins Scientific SE

ERF Neueste Nachrichten

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Eurofins Scientific SE (ERF) Börsenkurse

Eurofins Scientific SE (ERF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Eurofins Scientific SE

ERF Neueste Nachrichten

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen